CFO's recent share sale at current price raises caution. Lack of insider buying in past year, along with recent selling, calls for caution despite high insider ownership.
Despite the higher P/E ratio, investors continue to hold onto Targa Resources shares due to the company's promising future outlook. The strong earnings growth and positive future projections provide support for the current share price.
Significant insider selling in the past year at Targa Resources may indicate lack of confidence. However, their profitability, growth, and insider ownership suggest less concern. Still, potential investors should carefully consider these insider sales.
Targa's proposed dividend increase shows commitment to distribute more capital to shareholders, suggesting a positive future. CEO's post-earnings call declarations convey confidence in Permian volumes' future growth.
Targa executives remain confident in the company's continued growth despite a temporary dip in production volumes and are working on strategies to enhance export capacity. This demonstrates an optimistic outlook on Targa's future performance.
We're positive on midstream in 2023 due to solid fundamentals, strong FCF and attractive cash returns to shareholders. And with China reopening and strong European demand, U.S. LNG exports will remain strong, recommend LNG,TRG,EPD,ET,PAA. 1. Strong US LNG on robust Europe demand and low US prices. U.S. LNG exports will remain strong as Europe seeks to displace Russian gas supplies. As China reopens, there could be upward pressure on global LNG prices. ...
タルガリソースに関するコメント
コラムMidstream Energy | Earnings expected in 2023
1. Strong US LNG on robust Europe demand and low US prices. U.S. LNG exports will remain strong as Europe seeks to displace Russian gas supplies. As China reopens, there could be upward pressure on global LNG prices.
...
TOP WATCH 7/3 ⚡️⚡️
$エイピックス・メディカル(APYX.US)$$Addentax Group Corp(ATXG.US)$$アクサム・セラピューティクス(AXSM.US)$$バイオエクセル・セラピューティクス(BTAI.US)$$Baudax Bio(BXRX.US)$$CymaBay Therapeutics(CBAY.US)$$コーメディックス(CRMD.US)$$マリオット・インターナショナル(MAR.US)$$マイクロビジョン(MVIS.US)$$レナリティクスAI(RNLX.US)$$ステート・ストリート(STT.US)$$ツリーハウス・フーズ(THS.US)$$タルガリソース(TRGP.US)$$VBIウ゛ァクシンズ(VBIV.US)$$ベンタス(VTR.US)$
Apple Cut to $173 By Keybanc; Nvidia Reduced to $285 By Citigroup | Price Target Changes
$アップル(AAPL.US)$$JD.COM(京東商城)(JD.US)$$京東(09618.HK)$$JPモルガン・チェース(JPM.US)$$エヌビディア(NVDA.US)$$エスエイピー(SAP.US)$$タルガリソース(TRGP.US)$$アメリカン・エキスプレス(AXP.US)$$パブリック・サービス・エンタープライズ・グループ(PEG.US)$$タイラー・テクノロジーズ(TYL.US)$$ギャップ(GPS.US)$
コラムToday's pre-market stock movers: X, REV, ROKU, BHC and more
• $Revlon(REV.US)$ +81% (Reliance mulling buyout of REV according to Economic Times)
• $USスチール(X.US)$ +6.4% (issues upside EPS guidance),
• $エリントン・ファイナンシャル(EFC.US)$ +5% (reports book value per share)
• $オーロラ・モバイル(JG.US)$ +4.9% (receives RMB15 mln in special support funding from the Shenzhen Development and Reform Commission)
• $シティ・トレンズ(CTRN.US)$ +4.4% (names new CFO)
• $ロク(ROKU.US)$ +4.2% (ROKU an...
コラムToday's pre-market stock movers: STNE, ONON, USAS and more
In reaction to earnings/guidance:
• $ストーン(STNE.US)$ +28.4% (also announces executive hires), $オン・ホールディング(ONON.US)$ +8.27%, $アメリカズ・シルバー(USAS.US)$ +3.85%, $トーリッド・ホールディングス(CURV.US)$ +0.8%
Other news:
• $レキシコン・ファーマシューティカルズ(LXRX.US)$ +4.5% (enters into loan facility to support commercialization of sotagliflozin)
• $TMCザ・メタルズ(TMC.US)$ +3.2% (signs term sheet for development of commercial system to collect deep-sea pol...
まだコメントはありません